114 related articles for article (PubMed ID: 17405743)
1. Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.
Garderet L; Santacruz R; Barbu V; van den Akker J; Carbonne B; Gorin NC
Haematologica; 2007 Jan; 92(1):e9-10. PubMed ID: 17405743
[TBL] [Abstract][Full Text] [Related]
2. Successful pregnancy in a patient with chronic myeloid leukemia under treatment with imatinib.
Tsuzuki M; Inaguma Y; Handa K; Hasegawa A; Yamamoto Y; Watanabe M; Mizuta S; Maruyama F; Okamoto M; Emi N
Intern Med; 2009; 48(16):1433-5. PubMed ID: 19687593
[TBL] [Abstract][Full Text] [Related]
3. [Imatinib-New, molecular therapeutic possibility in chronic myeloid leukemia. The IRIS Study].
Berger U; Hehlmann R
Internist (Berl); 2004 Jan; 45(1):102-3. PubMed ID: 14735248
[No Abstract] [Full Text] [Related]
4. Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy.
Skoumalova I; Vondrakova J; Rohon P; Rozmanova S; Jarosova M; Indrak K; Prochazka M; Santava A; Faber E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):121-3. PubMed ID: 18795086
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome of two patients treated with imatinib.
Prabhash K; Sastry PS; Biswas G; Bakshi A; Prasad N; Menon H; Parikh PM
Ann Oncol; 2005 Dec; 16(12):1983-4. PubMed ID: 16100234
[No Abstract] [Full Text] [Related]
6. Bleomycin, etoposide and cisplatin (BEP) combination with concurrent imatinib mesylate (GLEEVEC) in chronic myeloid leukemia (CML) patient with mesenchymal tumor.
Coşkun HS; Göksu SS; Sahin M; Alanoğlu G
Med Oncol; 2008; 25(1):110-2. PubMed ID: 18188725
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of childhood Philadelphia chromosome-positive acute myeloid leukemia.
Chen X; Yang W; Zhu X
Pediatr Int; 2011 Aug; 53(4):598-600. PubMed ID: 21851498
[No Abstract] [Full Text] [Related]
8. [Tyrosine kinase inhibitors for the treatment of CML].
Heim D
Ther Umsch; 2006 Apr; 63(4):249-54. PubMed ID: 16689455
[TBL] [Abstract][Full Text] [Related]
9. Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib.
Heartin E; Walkinshaw S; Clark RE
Leuk Lymphoma; 2004 Jun; 45(6):1307-8. PubMed ID: 15360020
[No Abstract] [Full Text] [Related]
10. Successful delivery after planned discontinuation of imatinib in a patient with chronic myeloid leukemia.
Kobayashi K; Takebayashi C; Miyata S; Narimatsu H; Kami M
Intern Med; 2009; 48(5):369-71. PubMed ID: 19252364
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
Iqbal J; Ali Z; Khan AU; Aziz Z
Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission.
Ali R; Ozkalemkaş F; Ozçelik T; Ozkocaman V; Ozan U; Kimya Y; Köksal N; Gülten T; Yakut T; Tunali A
Leuk Res; 2005 Aug; 29(8):971-3. PubMed ID: 15978950
[TBL] [Abstract][Full Text] [Related]
13. Imatinib and pegylated IFN-α2b discontinuation in first-line chronic myeloid leukemia patients following a major molecular response.
Koskenvesa P; Kreutzman A; Rohon P; Pihlman M; Vakkila E; Räsänen A; Vapaatalo M; Remes K; Lundán T; Hjorth-Hansen H; Vakkila J; Simonsson B; Mustjoki S; Porkka K
Eur J Haematol; 2014; 92(5):413-20. PubMed ID: 24372965
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate induces cisplatin hypersensitivity in Bcr-Abl+ cells by differential modulation of p53 transcriptional and proapoptotic activity.
Skorta I; Oren M; Markwardt C; Gutekunst M; Aulitzky WE; van der Kuip H
Cancer Res; 2009 Dec; 69(24):9337-45. PubMed ID: 19934315
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy in patients with chronic myeloid leukemia treated with imatinib.
Yilmaz M; Demirhan O; Kuçukosmanoglu E; Pehlivan M; Okan V; Balat O; Pehlivan S
Leuk Lymphoma; 2007 Dec; 48(12):2454-6. PubMed ID: 18067024
[No Abstract] [Full Text] [Related]
16. [Efficacy of imatinib mesylate, a specific inhibitor of BCR/ABL tyrosine kinase, on chronic myeloid leukemia in blast phase].
Zhang GC; Zheng D; Li QH; Li XH; Cai CC; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
Ai Zheng; 2004 Dec; 23(12):1696-9. PubMed ID: 15601563
[TBL] [Abstract][Full Text] [Related]
17. Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
Preudhomme C; Guilhot J; Nicolini FE; Guerci-Bresler A; Rigal-Huguet F; Maloisel F; Coiteux V; Gardembas M; Berthou C; Vekhoff A; Rea D; Jourdan E; Allard C; Delmer A; Rousselot P; Legros L; Berger M; Corm S; Etienne G; Roche-Lestienne C; Eclache V; Mahon FX; Guilhot F; ;
N Engl J Med; 2010 Dec; 363(26):2511-21. PubMed ID: 21175313
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial.
Mahon FX; Réa D; Guilhot J; Guilhot F; Huguet F; Nicolini F; Legros L; Charbonnier A; Guerci A; Varet B; Etienne G; Reiffers J; Rousselot P;
Lancet Oncol; 2010 Nov; 11(11):1029-35. PubMed ID: 20965785
[TBL] [Abstract][Full Text] [Related]
19. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.
Hughes TP; Kaeda J; Branford S; Rudzki Z; Hochhaus A; Hensley ML; Gathmann I; Bolton AE; van Hoomissen IC; Goldman JM; Radich JP;
N Engl J Med; 2003 Oct; 349(15):1423-32. PubMed ID: 14534335
[TBL] [Abstract][Full Text] [Related]
20. The effects of imatinib on pregnancy outcome.
Pye SM; Cortes J; Ault P; Hatfield A; Kantarjian H; Pilot R; Rosti G; Apperley JF
Blood; 2008 Jun; 111(12):5505-8. PubMed ID: 18322153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]